Importantly, our study demonstrated that CCL28 blockade upon FOSL2 overexpression exerted a potent anti-tumour effect by suppressing Treg cell infiltration and might serve as a potential therapeutic target for pancreatic cancer. The gene discussed is CCL28; the disease is neoplasm.